About Michael Singer
Michael Singer is a senior advisor and director at Anodyne Nanotech.
Michael Singer reports to the SEC as a director or major shareholder of 1 public company: Cartesian Therapeutics (RNAC).
Michael Singer first appears on SEC filings in 2020.
Experience
This experience comes from Michael Singer's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Singer in the role, so the role may have started earlier or lasted longer.
BS
Boston Cell Standards Current
Board of Directors
2024 – Present
Anodyne Nanotech, Inc. Current
Senior Advisor and director
Board of Directors (2020 – Present)
2020 – Present · Boston, MA
Develops skin patches to deliver medicines for people with chronic diseases.
PT
Pykus Therapeutics Current
Board of Directors
2019 – Present
YU
Yale University Current
Entrepreneur-in-Residence (Volunteer) (2017 – Present)
Scientific Advisory Board (2022 – Present)
2017 – Present
CI
Cartesian Therapeutics, Inc. Current
Director and 10% owner
Board of Directors (2016 – Present)
2016 – Present · Public company (RNAC)
BS
BioPorto Diagnostics A/S
Board Of Directors
2019 – 2025
TT
Topokine Therapeutics
Co-Founder, Chief Scientific Officer, Board of Directors
2012 – 2016
HS
Harvard Medical School
Clinical Faculty
2002 – 2015
NR
Novartis Institutes for Biomedical Research
Director, Translational Medicine
2009 – 2012
HC
HealthHonors Corporation
Co-Founder, Chief Scientific Officer, and Board of Directors
2005 – 2009
HP
Harvard Ophthalmology Residency Program
Resident in Ophthalmology
2003 – 2006
BS
Brigham and Women's Hospital / Harvard Medical School
Medical House Officer
2002 – 2003
Key Colleagues at Startups
The people Michael Singer works with at each company, as listed on that company's latest Form D.
Anodyne Nanotech, Inc. · Form D, Jun 11, 2026
VL
Vikram Lamba
Director
GP
Georgios Papastergiou
Director
KT
Konstantinos Tzortzakis
Co-Founder & CBO, director
LJ
Lombardo Jake
Executive officer and director